These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 1070710)

  • 1. [Membrane glycoproteins and platelet protein glycosylation in chronic myeloid leukemia].
    Vainer H; Bussel A
    Nouv Rev Fr Hematol (1978); 1976; 16(3):447-54. PubMed ID: 1070710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Altered platelet surface glycoproteins in chronic myeloid leukemia (author's transl)].
    Vainer H; Bussel A
    Int J Cancer; 1977 Feb; 19(2):143-9. PubMed ID: 264846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on platelet plasma membranes. I. Characterization of surface proteins of human platelets labeled with diazotized (125i)-diiodosulfanilic acid.
    George JN; Potterf RD; Lewis PC; Sears DA
    J Lab Clin Med; 1976 Aug; 88(2):232-46. PubMed ID: 60457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on platelet plasma membranes. II. Characterization of surface proteins of rabbit platelets in vitro and during circulation in vivo using diazotized (125i)-diiodosulfanilic acid as a label.
    George JN; Lewis PC; Sears DA
    J Lab Clin Med; 1976 Aug; 88(2):247-60. PubMed ID: 956684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular defects of platelets in Bernard-Soulier syndrome.
    Nurden AT; Didry D; Rosa JP
    Blood Cells; 1983; 9(2):333-58. PubMed ID: 6229301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of carriers in Glanzmann's thrombasthenia.
    Zonneveld GT; van Leeuwen EF; Sturk A; ten Cate JW
    Thromb Haemost; 1983 Jun; 49(3):182-6. PubMed ID: 6224309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunochemical evidence for protein abnormalities in platelets from patients with Glanzmann's thrombasthenia and Bernard-Soulier syndrome.
    Hagen I; Nurden A; Bjerrum OJ; Solum NO; Caen J
    J Clin Invest; 1980 Mar; 65(3):722-31. PubMed ID: 7354135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combining ability of glycoproteins IIb, IIIa and Ca2+ in EDTA-treated nonaggregable platelets.
    Zucker MB; Varon D; Masiello NC; Karpatkin S
    Thromb Haemost; 1983 Dec; 50(4):848-51. PubMed ID: 6320488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of wheat germ agglutinin and concanavalin A with platelets. Stimulation of platelet functional reactions and binding with membrane glycoproteins.
    Smirnova IV; Khaspekova SG; Ignatov VV; Mazurov AV
    Biochemistry (Mosc); 1998 Jun; 63(6):710-8. PubMed ID: 9668212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A variant of Glanzmann's thrombasthenia with abnormal glycoprotein IIb-IIIa complexes in the platelet membrane.
    Nurden AT; Rosa JP; Fournier D; Legrand C; Didry D; Parquet A; Pidard D
    J Clin Invest; 1987 Mar; 79(3):962-9. PubMed ID: 3818957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralization of the local negative charge carried by glycoprotein (GP)-Ib in ristocetin-induced platelet agglutination.
    Tanoue K; Jung SM; Yamamoto N; Yamazaki H
    Thromb Haemost; 1984 Feb; 51(1):79-83. PubMed ID: 6232731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Variant of Paris-I Lariboisière thrombasthenia, a molecular anomaly of the IIb-IIIa platelet glycoprotein complex].
    Caen JP; Rosa JP; Soria C; Boizard B
    C R Seances Acad Sci III; 1983; 296(10):479-81. PubMed ID: 6223690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion.
    Moroi M; Jung SM; Okuma M; Shinmyozu K
    J Clin Invest; 1989 Nov; 84(5):1440-5. PubMed ID: 2808700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of human platelet membrane fibrinogen receptors by immunochemical techniques.
    Kornecki E; Tuszynski GP; Niewiarowski S
    Haematologia (Budap); 1984; 17(3):387-98. PubMed ID: 6100105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms underlying increased platelet reactivity in patients with peripheral arterial disease. Preliminary results.
    Reininger CB; Boeger CA; Steckmeier B; Spannagl M; Scweiberer L
    Int Angiol; 1999 Jun; 18(2):163-70. PubMed ID: 10424375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional fractionation of platelets: aggregation kinetics and glycoprotein labeling of differing platelet population.
    Haver VM; Gear AR
    Thromb Haemost; 1982 Oct; 48(2):211-6. PubMed ID: 6294898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometric analysis of platelet surface glycoproteins: phenotypically distinct subpopulations of platelets in children with chronic myeloid leukemia.
    Michelson AD
    J Lab Clin Med; 1987 Sep; 110(3):346-54. PubMed ID: 3475397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanism of the interaction of subendothelial microfibrils with blood platelets.
    Legrand YJ; Fauvel-Lafève F
    Nouv Rev Fr Hematol (1978); 1992; 34(1):17-25. PubMed ID: 1326097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane changes associated with platelet activation. Exposure of actin on the platelet surface after thrombin-induced secretion.
    George JN; Lyons RM; Morgan RK
    J Clin Invest; 1980 Jul; 66(1):1-9. PubMed ID: 6772667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific protein and glycoprotein deficiencies in platelets isolated from two patients with the gray platelet syndrome.
    Nurden AT; Kunicki TJ; Dupuis D; Soria C; Caen JP
    Blood; 1982 Apr; 59(4):709-18. PubMed ID: 6460535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.